Lectures

Earning CPD by listening to Healthed podcasts is simple. Each episode is eligible for Educational Activities CPD.

Filter results

Prof Genie Pedagogos, Prof Richard MacIsaac & A/Prof Ralph Audehm
0.5 EA

Advice and evidence for and role of GLP-1 receptor agonists in the prevention and management of kidney disease in patients with type 2 diabetes will be discussed.

Prof Rodney Baber AM
0.5 EA

An overview of the evidence and the current recommendations in terms of MHT's role in preventing cardiovascular disease will be discussed as well as its safety in women with pre-existing cardiovascular disease.

Dr Gabby Mahoney
0.5 EA

Evidence-based recommendations for managing eczema will be discussed including other relevant issues such as key triggers, managing discoid eczema and when referral might be appropriate.

Prof Deborah Bateson AM
0.5 EA

Explore "natural oestrogens" as emerging contraceptive options - their biological basis, current evidence, safety claims, and how clinicians can guide patients through informed, evidence-based prescribing decisions.

Prof Rodney Baber AM
0.5 EA

This lecture will clarify risk concepts in MHT, helping GPs understand and apply terms like absolute risk and hazard ratios in clinical decision-making.

Dr Sushil Pant
0.5 EA

A practical and comprehensive framework for the assessment, investigation and management of patients with acutely painful shoulder will be discussed.

Expert/s: Dr Sushil Pant
Dr Richard Phoon
0.5 EA

The evidence for the effectiveness of new drug options for chronic disease will be discussed, including when, how and in whom they should be prescribed to.

Prof Peter Richmond
0.5 EA

This lecture equips GPs with practical updates on IPD vaccination - who, when, which vaccine, funding, and high-risk patient groups.

Dr Ted Wu
0.5 EA

Dr Ted Wu discussed the opportunities and challenges that future research into cardiovascular outcomes in patients with type 2 diabetes are likely to encounter.

Expert/s: Dr Ted Wu
A/Prof Spiros Fourlanos & Samantha Stuk
0.5 EA

This presentation discuss the risk of nutritional deficits and loss of muscle mass associated with the use of GLP-1 receptor agonists and recommendations on how to reduce these risks.

A/Prof Ralph Audehm & A/Prof Jeremy Grummet
0.5 EA

Changes to the Australian prostate cancer screening guidelines will be discussed including the updated risk: benefit profile for PSA testing, who should be tested and how test results should be interpreted and managed.

Dr Alison Chiu

Dr Alison Chiu provides an update on the pathophysiology of dry eye and who is at risk of developing this condition.

Expert/s: Dr Alison Chiu

Advice and evidence for and role of GLP-1 receptor agonists in the prevention and management of kidney disease in patients with type 2 diabetes will be discussed.

An overview of the evidence and the current recommendations in terms of MHT's role in preventing cardiovascular disease will be discussed as well as its safety in women with pre-existing cardiovascular disease.

Evidence-based recommendations for managing eczema will be discussed including other relevant issues such as key triggers, managing discoid eczema and when referral might be appropriate.

Explore "natural oestrogens" as emerging contraceptive options - their biological basis, current evidence, safety claims, and how clinicians can guide patients through informed, evidence-based prescribing decisions.

This lecture will clarify risk concepts in MHT, helping GPs understand and apply terms like absolute risk and hazard ratios in clinical decision-making.

A practical and comprehensive framework for the assessment, investigation and management of patients with acutely painful shoulder will be discussed.

Expert/s: Dr Sushil Pant

The evidence for the effectiveness of new drug options for chronic disease will be discussed, including when, how and in whom they should be prescribed to.

This lecture equips GPs with practical updates on IPD vaccination - who, when, which vaccine, funding, and high-risk patient groups.

Dr Ted Wu discussed the opportunities and challenges that future research into cardiovascular outcomes in patients with type 2 diabetes are likely to encounter.

Expert/s: Dr Ted Wu

This presentation discuss the risk of nutritional deficits and loss of muscle mass associated with the use of GLP-1 receptor agonists and recommendations on how to reduce these risks.

Changes to the Australian prostate cancer screening guidelines will be discussed including the updated risk: benefit profile for PSA testing, who should be tested and how test results should be interpreted and managed.

Dr Alison Chiu provides an update on the pathophysiology of dry eye and who is at risk of developing this condition.

Expert/s: Dr Alison Chiu